Fortress Biotech repays remaining $15 million in debt in full
FBIO•Fortress Biotech repaid the remaining $15 million in principal under its senior secured credit agreement with Oaktree in September 2026, satisfying all indebtedness under the agreement.
1. Debt repaid
Fortress Biotech repaid the remaining $15 million in outstanding principal under its senior secured credit agreement with Oaktree in September 2026. The repayment satisfied all indebtedness under the agreement.




